Stay updated on Nivolumab+SAbR in Metastatic Clear Cell Renal Cell Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab+SAbR in Metastatic Clear Cell Renal Cell Carcinoma Clinical Trial page.

Latest updates to the Nivolumab+SAbR in Metastatic Clear Cell Renal Cell Carcinoma Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.4.2 was added and the previous government funding notice and Revision: v3.4.1 were removed.SummaryDifference0.4%

- Check21 days agoChange DetectedThe page now includes a site-wide notice about government funding and NIH operations, and the page revision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check28 days agoChange DetectedAdded a Show glossary feature and updated the page revision to v3.4.0; capitalization tweaks were made to QC criteria wording and FEAR Act data, replacing the previous v3.3.4 text.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision update: v3.3.4 added and v3.3.3 removed; no changes to study content or displayed data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check64 days agoChange DetectedAdded a dedicated Locations section with Texas as the site and removed the prior Texas Locations entry. The page revision updated to v3.3.3 and the HHS Vulnerability Disclosure link was removed.SummaryDifference0.2%

- Check85 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2; this is a minor versioning change with no user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Nivolumab+SAbR in Metastatic Clear Cell Renal Cell Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab+SAbR in Metastatic Clear Cell Renal Cell Carcinoma Clinical Trial page.